Home
Storia in 2 fonti
Samsung Bioepis launches first biosimilar in Japan
Samsung Bioepis said Wednesday it has launched autoimmune disease treatment SB17 in partnership with Nipro Corporation, marking the company’s first product laun
- ·
koreaherald.com
Samsung Bioepis launches first biosimilar in Japan
Samsung Bioepis said Wednesday it has launched autoimmune disease treatment SB17 in partnership with Nipro Corporation, marking the company’s first product laun
- ·
koreatimes.co.kr
Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro - The Korea Times
Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country und...